M. Bogdan (Bucharest, Romania), G. Funk (Vienna, Austria)
Readmissions after hospitalization for acute exacerbation of chronic obstructive pulmonary disease
Y. Wang, S. Humerfelt, H. Lurås, F. A. Dahl, K. Stavem, T. Haugen (Lørenskog, , Oslo, Norway)
|  |
Role of testosterone in acute exacerbation of chronic obstructive pulmonary disease: Relationship with severity indices
A. DI Marco Berardino, R. Inchingolo, G. M. Corbo, A. Mancini, E. Leone, S. Valente (Rome, Italy)
|  |
Relationship between dietary energy intake and clinical status in patients with exacerbation of chronic obstructive pulmonary disease (COPD)
A. Fisenko, M. Sanzharovskaya, G. Chernogoryuk (Tomsk, Russian Federation)
| |
Effects of a concomitant therapy with Cineole (Eucalyptole) on exacerbation rate in COPD: A placebo-controlled double-blind trial
H. Worth, C. Schacher, U. Dethlefsen (Fürth, Aachen, Germany)
| |
EABPCO-CPHG study: Prognosis factors of death and/or hospital admission in 1,142 patients, at 3 months after their admission to the pneumology department of a French general hospital for COPD acute exacerbation (AE)
J. Piquet, J. M. Chavaillon, C. Maurer, M. Zureik, N. Roche, F. Blanchon (Montfermeil, Antibes, Paris, Meaux, France)
| |
Quality of life doesn‘t predict late discharge in hospitalisations for COPD exacerbations
S. Antoniu, B. Zaharia, A. Puiu, D. Azoicai (Iasi, Romania)
| |
Comorbidities, hospitalizations and the risk for readmission after AE COPD – Longitudinal study
A. Nowinski, D. Kaminski, D. Korzybski, M. Bednarek, D. Gorecka (Warsaw, Poland)
| |
Long-term azithromycin therapy in severe COPD with repeated exacerbations
J. Casabon, X. Pomares, C. Monton, C. Veigas, A. Garcia, M. Espasa, M. Gallego, A. Marin (Sabadell, Spain)
| |
The frequency of gastroesophageal reflux in acute attacks of COPD
E. Çil, I. Karasu, A. Özsöz, E. Özbilek (Izmir, Turkey)
| |
Early admission predictors in COPD patients admitted at hospital for an exacerbation
A. Muñoz, C. Martinez Rivera, P. Serra, E. Molins, A. B. Aran, I. Garcia Olivé, J. Abad Capa, M. Prats Bardají, J. Ruiz Manzano, J. Morera Prat (Badalona, Spain)
| |
Lung hyperinflation, dyspnoe, and exercise tolerance in patients with COPD exacerbation
S. Skoczynski, K. Mizia-Stec, A. Semik-Orzech, E. Sozanska, Z. Gasior, W. Pierzchala (Katowice, Poland)
| |
Mortality predictors in COPD exacerbation
M. D. P. Cano Aguirre, R. M. Girón Moreno, C. Martín Carbajo, J. A. García Romero de Tejada, C. Pinedo Sierra, G. Segrelles Calvo, E. Vázquez Espinosa, J. Anchochea Bermúdez (Madrid, Toledo, Spain)
| |
Supported discharge programmes, 2008 UK national COPD audit
J. Kastelik, D. Lowe, R. A. Stone, C. M. Roberts (Cottingham, London, Taunton, United Kingdom)
| |
The audit-intervention-reaudit cycle can improve diagnostic standards for chronic obstructive pulmonary disease (COPD)
M. Lusuardi, G. Garuti, M. Massobrio, L. Spagnolatti, D. Orlandini (Correggio, Reggio Emilia, Italy)
| |
A causal relationship between COPD exacerbations and quality of life scores
E. Chavignay, M. Gregory, N. Gregory (Montpellier, France; Montréal, Canada)
| |
Muscle weakness and ADO-index determine length of hospital stay for an acute COPD exacerbation
A. Lehouck, C. Carremans, M. Decramer, W. Janssens (Belgium)
| |
Evaluation of COPD exacerbations using the EXACT-U
J. Petrillo, J. Cairns (London, United Kingdom)
| |
Reductions in COPD Exacerbations with Tiotropium Compared to Salmeterol
C. Vogelmeier, B. Hederer, T. Glaab, H. Schmidt, M. Rutten-van Moelken, K.-M. Beeh, K.F. Rabe, L.M. Fabbri (Marburg, Germany; , ; Leiden, Netherlands; Modena, Italy)
| |